Last reviewed · How we verify

NCT07342361

Using Retrograde Intrarenal Surgery for Managing Staghorn Renal Stones.

Recruiting now NA Last updated 3 February 2026
What this trial tests

NA trial testing Retrograde intrarenal surgery in Renal Calculi in 100 participants. Currently enrolling.

Timeline
20 January 2026
Primary endpoint
10 October 2026
1 December 2026

Quick facts

Lead sponsorHelwan University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment100
Start date20 January 2026
Primary completion10 October 2026
Estimated completion1 December 2026
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Helwan University

Who can join

Adults 18 to 70, any sex, with Renal Calculi. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This prospective, randomized study is comparing the safety and efficacy of using two types of ureteral access sheaths in managing staghorn renal stones by retrograde intrarenal surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Retrograde intrarenal surgery

Trials testing the same drug.

Other recruiting trials for Renal Calculi

Currently open trials in the same condition.

Other Helwan University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07342361.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing